The round was joined by Hangzhou government-backed Wanxiang Investment and Hangzhou Lianchuan Investment and reportedly values Helian Health at $900 million. The post Chinese AI unicorn Sensetime leads $75m Series B for Helian Health appeared first on DealStreetAsia.